bpc-157 for ulcerative colitis Post from Dr. Jones, DC JPP No 5/2013 article 09

JPP No 5 2013 article 09 FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for An FDA Committee Just Voted in Favor of PeptidesDespite the Agency's Opposition FDA Discusses Peptide Bulk Substances BPC 157 and More Hillary Lin, MD posted on the topic LinkedIn BPC 157 Peptide Guide: Research, Benefits, Mechanisms, and Current Science The Peptide Research Podcast Podcast on Spotify

SKU: 15544656939 · From southroadsurgery.com.au